Large vs. Small Molecules in Biopharmaceuticals

Abstract:

Biopharmaceuticals have emerged as the next-gen of therapeutic (large and small) molecules in the pharmaceutical industry. Dr. Chad Eichman, Biopharmaceutical Industry Manager, Phenomenex reviews the increase in pharmaceutical R&D efforts toward biologics products, and the shift seen within analytical companies towards novel solutions for biologics characterization.

Document Type:

Technical Notes

Industries:

Pharmaceutical/Biopharmaceutical Life Science

Techniques:

HPLC / UHPLC

Brands:

bioZen

PDF Link:

Click here